Additional information
| Active substance | Levocetirizine |
|---|---|
| Water Retention | Negligible |
| Hepatotoxicity | Low |
| Lab Test | Not routinely required |
| Strength | 5mg |
| Also known as | Levocetirizine dihydrochloride |
| Blood pressure | Generally does not affect blood pressure significantly |
| Trade name | Xyzal |
| Storage conditions | Store at room temperature, away from excess heat and moisture |
| Chemical name | (R)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid |
| Formula | C21H25ClN2O3 |
| Substance class | Antihistamine |
| Main action | H1 histamine receptor antagonist |
| Half-life | 6 to 10 hours |
| Dosage (medical) | 5 mg once daily |
| Dosage (sports) | Not applicable |
| Effects | Relief from allergic symptoms such as sneezing, runny nose, itchy or watery eyes, and hives |
| Side effects | Drowsiness, fatigue, dry mouth, headaches |
| Use in sports | No specific use in sports |
| Manufacturer | Cipla Ltd. |
| Packing | 10 tabs/blister |
|
Reviews
There are no reviews yet.